BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
2441 – 2450 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements.
(
- Contribution to journal › Letter
-
Mark
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
(
- Contribution to journal › Article
-
Mark
Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression
(
- Contribution to journal › Article
-
Mark
Chromosome 19 Annotations with Disease Speciation - A First Report from the Global Research Consortium
(
- Contribution to journal › Article
-
Mark
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
(
- Contribution to journal › Article
-
Mark
The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.
(
- Contribution to journal › Article
-
Mark
miR-155 meets the JAK/STAT pathway.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Enhanced SOX10 and KIT expression in cutaneous melanoma.
(
- Contribution to journal › Letter
-
Mark
Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase.
(
- Contribution to journal › Article
-
Mark
The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
(
- Contribution to journal › Article